The SMI concluded the week of December 22-26, 2025, on a high note, reflecting its status as a premier safe-haven destination during a period of global macroeconomic recalibration. Despite the characteristic low volumes of the holiday season, the index achieved a fresh record high near 13,288 before settling, buoyed by stabilizing domestic inflation and a robust corporate outlook for the coming year.

Defensive Dominance and Sector Stability

The index’s performance this week was underpinned by its core defensive sectors , which traditionally provide stability during volatile cycles. Healthcare giants Novartis (+1.27%) and Roche (+1.38%) led the charge, offsetting minor 7-day dips in consumer staples like Nestlé . This rotation back into quality, large-cap equities highlights the attractive risk-reward profile of the Swiss market for global investors. Furthermore, the financial sector remained steady, with UBS Group showing resilience as it navigates a higher interest rate environment than its recent historical averages, even as the broader capital market anticipates more central bank easing abroad.

SNB Policy and Macroeconomic Stability

A critical factor supporting the SMI’s trajectory is the Swiss National Bank’s recent decision to hold interest rates at 0% . With annual inflation dropping to 0.0% in November , the SNB has effectively shifted to a wait-and-see mode to assess the delayed impact of previous cuts. While GDP growth is expected to remain modest at approximately 1.5% for 2025 and 1% for 2026 , the central bank’s readiness to intervene in the foreign exchange market provides a safety net against excessive appreciation of the franc. This policy consistency offers a stable backdrop for Swiss exporters who face potential challenges from shifting US trade policies.

Global Integration and the 2026 Outlook

For investors in Israel and other global hubs, the SMI represents a critical component of a diversified investment portfolio . The index’s heavy weighting in healthcare and technology aligns with the long-term structural themes of digital transformation and demographic shifts that are currently driving private market interest. As institutional sentiment for 2026 leans toward optimism—particularly for European equities—the SMI is positioned to benefit from increased allocations toward regions with high political stability and transparent regulation.

The outlook for the SMI remains cautiously bullish, with analysts projecting a further 6% to 11% upside as global financing conditions ease and corporate earnings efficiencies continue to improve. However, the path forward is not without risks; investors must closely monitor US trade policy and the potential for a “black swan” event in the global energy markets. Should the Swiss franc maintain its strength without stifling export growth, the SMI is well-placed to sustain its momentum and potentially reach new milestones in the first quarter of 2026.